ArticleCancer science2021

Phase I study of the antiprogrammed cell death-1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies.

Hironobu Minami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.